Guest guest Posted February 9, 2002 Report Share Posted February 9, 2002 Subj: Anti-cancer compounds Date: 21/Jan/02 6:57:14 PM GMT Standard Time From: faith@... (faith) To: hlai@..., Kosmostarr@..., drphatak@... Dear Dr. Lai, Congratulations and thanks for your work to cure cancer. As I had a mastectomy at 40, this could relieve the fear that my daughter might one day face the same fate. Linus ing believed most cancer research to be a hoax. Drug manufacturers and medical services don't want to see an afordable cure. (Cancer alleged to be the second biggest money spinning activity - petrochemicals is first.) Attached article on the work of Prof. Manju Ray, Calcutta, appears to be largely ignored, to support Prof. ing. Compounds that can alter the structure of the biologically active particles (L-forms) produced when microbes distintegrate, may inhibit their ability to evolve to original and/or atypical forms (mycoplasma). Some protozoa and mycoplasma can sequester nucleotides to produce excess ATP, to excite malignancy. The most difficult part of your work may be in getting the value of the treatment known and used. With best wishes, Sincerely, Faith H. Sood [image] Nutrition Home Page New Patients Help FREE Weekly Health Newsletter Indian Cancer Solution " Methylglyoxal " Your Email Indian cancer researchers have taken a giant step on Address: the road to discovering a solution for cancer by developing a drug that selectively targets the cancer cells without harming the healthy ones. Read Past Issues Researchers in Kolkata claim that patients in " very Issue 228 advanced stages " of cancer for whom all other treatments had failed have been brought back to June 13, 2001 " excellent " health with the help of a drug formulation they have developed after research Parents Still spanning more than a decade. Don’t Understand the Truth About " We have what we think magic bullet against cancer, " Fevers says Manju Ray, a biochemist at the Indian Association of the Cultivation of Science (IACS) Next Surgeon where the drug was developed under a project funded General of the US by the Department of Science and Technology and the is One of My Council of Scientific and Industrial Research. Heroes Most currently available anti-cancer drugs are toxic How Safe is Soy because they also damage the normal cells. Ray says Infant Formula? the IACS formulation, containing " Methylglyoxal " as the lead ingredient, combats only the diseased cells, An Automated IVF the cherished goal of cancer researchers worldwide. Chip Could Lead Methylglyoxal is a metabolite in the human body to produced during glucose breakdown. Production-Line Babies Others involved in the project are Swapna Ghosh of IACS, Manoj Kar and Subhankar Ray of the University Autism 'Linked to College of Science, and Santajit Datta, a medical Mercury Vaccine' practitioner. Results of human trial conducted by them with the new drug have recently appeared in the Raw Veganism, Indian Journal of Physics. Biblical Nutrition, and While Americans are going ga-ga with their new Health Principles anticancer drug " Glivec " - that was featured on the cover of May 28 issue of Time magazine - the High-Grain Cattle low-profile, cash-strapped Kolkata researchers have Diets Cause Drug been working quietly for over a decade shunning Need publicity until they obtained proof from human trials nine weeks ago. Indian Cancer Solution According to their published paper, the " Methylglyoxal " Methylglyoxal-based formulation had " a dramatic positive effect on the patients " . Site Search For instance, the condition of 11 out of the 19 Free Newsletter patients treated - most of them in a very advanced stage when the treatment began -- are now stated to Read this first be in " excellent physical condition " . Five are in stable condition and only three died during the course of the study. Since the submission of the paper, the number of patients treated has crossed 40 mark with more than 70 per cent success, according to Manju Ray. Most remarkable fact, according to the scientists was that Methylglyoxal was successful against different types of cancer unlike " Glivec " which targets only the chronic myeloid leukemia. Those whose health returned to " excellent " condition after treatment with Methylglyoxal included patients in " a very advanced stages " of colon cancer, acute myeloid leukemia, non-Hodgkin's lymphoma, and cancers of ovary, breast, liver, lung, bone, gall bladder, pancreas and oral cavity. The patients were inducted for the trial, from January to June 2000, after obtaining permission from the Drug Controller General of India, the scientists said. The drug was administered orally for about six months with gradual reduction of daily dosage from the initial 25 milligrams per kilogram of body weight. Researchers said development of the drug was preceded by years of basic research involving human cancer cells in culture and animal experiments that showed that Methylglyoxal selectively killed the cancer cells without affecting normal cells by exploiting " a very significant " biochemical difference between the two. Explaining the mechanism of action, the scientists said cancer cells required a large amount of energy providing substance called ATP (Adenosine-5-Triphosphate) for survival. " Methylglyoxal inactivates the enzyme (Glyceraldehyde-3- Phosphate Dehydrogenase) needed for ATP production in cancer cells and thereby starves them to death. Normal cells remain unaffected. " Manju ray said that chemists knew Methylglyoxal molecule for about four decades and its anticancer effects in animals had also been studied. " But surprisingly, no one bothered to initiate further research leading to human trials, " she said. The researchers said concern in some quarters about safety of Methylglyoxal were not borne out from the clinical trials, which showed that in combination with protective agent like Ascorbic Acid and vitamins, the drug Methylglyoxal had no major toxic effect. They said there was scope for further enhancing the drug's efficacy. Hindustan Times Hyderabaad May 28, 2001 ------------------------------------------------------ DR. MERCOLA'S COMMENT: I normally do not focus on cancer as it is such a controversial area and is not something I have carefully studied. However, I am confident that the first step of cancer therapy is an aggressive application of the food choice program that I have developed with special attention to the vegetable juicing program and avoiding ALL types of sugar, as sugar serves as a major fuel source for cancer cells (see link below). Of course, the best approach is to start your optimized food choices prior to cancer arriving, as you will most likely prevent the cancer from ever having occurred in the first place. However, methylglyoxal does appear to be a promising agent with much potential. If anyone knows how to obtain this agent please contact me. Related Articles: Cancer's Sweet Tooth Start Natural Medicine BEFORE Cancer Arrives [image] If you find this newsletter interesting and valuable, help support it by recommending it to some friends by using this button. Return to Table of Contents #228 Home Page Health Articles Nutrition Help Newsletter ©Copyright 1997-2001 by ph M. Mercola, DO. All Rights Reserved. This content may be copied in full, with copyright; contact; creation; and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Mercola is required. ------------------------------------------------------------------------ Disclaimer - Newsletters are based upon the opinions of Dr. Mercola. They are not intended to replace a one-on-one relationship with a qualified health care professional and they are not intended as medical advice. They are intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. ----------------------- Headers -------------------------------- Return-Path: Received: from rly-za02.mx.aol.com (rly-za02.mail.aol.com [172.31.36.98]) by air-za05.mail.aol.com (v83.30) with ESMTP id MAILINZA59-0121135713; Mon, 21 Jan 2002 13:57:13 -0500 Received: from giaspn01.vsnl.net.in (giaspn01.vsnl.net.in [202.54.10.1]) by rly-za02.mx.aol.com (v82.22) with ESMTP id MAILRELAYINZA28-0121135643; Mon, 21 Jan 2002 13:56:43 -0500 Received: from giaspn01.vsnl.net.in (unknown [203.197.84.36]) by giaspn01.vsnl.net.in (Postfix) with ESMTP id 89F6E3E6; Tue, 22 Jan 2002 00:26:35 +0530 (IST) Message-ID: Date: Tue, 22 Jan 2002 00:51:55 +0530 X-Mailer: Mozilla 4.7 [en] (Win98; I) X-Accept-Language: en MIME-Version: 1.0 To: hlai@..., Kosmostarr@..., drphatak@... Subject: Anti-cancer compounds Content-Type: multipart/mixed; boundary= " ------------CD54E39C14A2B99643287ECA " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.